Ralph Knöll

13PUBLICATIONS
60CO-AUTHORS
Gene and molecular therapyTissue engineeringCardiology (incl. cardiovascular diseases)Energy generation, conversion and storage (excl. chemical and electrical)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 10, 2022
Antisense Therapy Attenuates Phospholamban p.(Arg14del) Cardiomyopathy in Mice and Reverses Protein Aggregation.

Tim R Eijgenraam, Nienke M Stege, Vivian Oliveira Nunes Teixeira

|Nov 03, 2021
Truncated titin proteins and titin haploinsufficiency are targets for functional recovery in human cardiomyopathy due to <i>TTN</i> mutations.

Andrey Fomin, Anna Gärtner, Lukas Cyganek

|Aug 31, 2021
Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy.

Niels Grote Beverborg, Daniela Später, Ralph Knöll

|Aug 17, 2021
Titin kinase ubiquitination aligns autophagy receptors with mechanical signals in the sarcomere.

Julius Bogomolovas, Jennifer R Fleming, Barbara Franke

|Jul 02, 2021
The Combined Human Genotype of Truncating <i>TTN</i> and <i>RBM20</i> Mutations Is Associated with Severe and Early Onset of Dilated Cardiomyopathy.

Anna Gaertner, Julia Bloebaum, Andreas Brodehl

|Dec 23, 2020
The Degree of Cardiac Remodelling before Overload Relief Triggers Different Transcriptome and miRome Signatures during Reverse Remodelling (RR)-Molecular Signature Differ with the Extent of RR.

Patrícia G Rodrigues, Daniela Miranda-Silva, Xidan Li

Pageof 3

Frequent Collaborators

3 joint publications

Zaher Elbeck

2 joint publications

Anna Gärtner

2 joint publications

Andreas Brodehl

2 joint publications

Henrik Fox